Revenue Cycle

Medicare's drug program enrollment growing

Patient Access Weekly Advisor, Forbes, February 6, 2008

Want to receive articles like this one in your inbox? Subscribe to Patient Access Weekly Advisor!

The number of enrollees in the three-year-old Medicare Part D drug program is climbing, even as costs for the program drop, U.S. health officials announced last week, according to a Forbes report.

"Overall, costs for beneficiaries and taxpayers are considerably lower than originally projections, enrollment continues to rise and customer satisfaction remains very high," Kerry Weems, acting administrator at the US Centers for Medicare and Medicaid Services (CMS), told reporters.

But many others criticize the program for its high co-pays on some drugs, its inability to negotiate lower prices with the drug industry, and its overall complexity, Forbes reports.

To read the full story, click here.



Want to receive articles like this one in your inbox? Subscribe to Patient Access Weekly Advisor!

Comments

0 comments on “Medicare's drug program enrollment growing

 

    Recovery Auditor Report
  • Recovery Auditor Report

    The Recovery Auditor Report is a free biweekly e-newsletter of useful tips and strategies to get you prepared for the...

  • Medicare Update for CAHs

    Medicare Update for CAHs is a free bi-weekly ezxne that provides specialized information for our CAH (critical access...

Most Popular

Related Articles